Our Clients Are Special To Us.
When Mobius receives a request for proposal from a previous or present client, we believe we have achieved success.
On our sixth project for one client, and with many more coming back to us for their next phase trials, we are extremely proud to know we’ve done a great job!
What Our Clients Say
To be clear, I was skeptical about ‘farming out’ this critical activity. These were early stage feasibility evaluations and our company’s success would pivot upon the study results. Our company was eager to move quickly and Mobius assured compliance with legal and ethical obligations without unduly compromising speed. After my first experience with your company, it was easy to return for subsequent engagements.
In each instance, the quality of the data we gathered was excellent. I credit Mobius for this. Mr. Czyniewski did an excellent job training the site coordinators in the requirements of the protocol and was quick to perform the first monitoring visits to correct and deficiencies early. What’s more, he did so with constant attention to the financial impacts, being sensitive to the fact that ours was a small company with tight financial constraints.
I am happy to serve as a reference for potential future clients. You may pass along my name and contact information freely.
As a full service Australian based CRO, Mobius Medical has provided each of my companies with a broad range of services in the many varied aspects of medical device development and clinical trial research, including early concept ideation and prototype development, regulatory guidance, Australian related strategic business planning and market development, physician recruitment, as well as all aspects of clinical trial execution.
They have assisted me with multiple, varied clinical trials, including early stage feasibility and first-in-man studies to an international, FDA regulated IDE study that ultimately resulted in FDA acceptance of the data and successful PMA approval in the United States for the device under investigation. Their work has always been performed in a timely, thorough and competent manner, and I have been able to consistently rely on them as the regional backbone for all of the business and research endeavours my companies have undertaken in Australia.
The single most crucial attribute that Mobius Medical provides is their personnel: They have staffed an incredibly skilful, competent, and reliable team which is second to none. The Directors of Mobius Medical each have unique credentials, experience and talents, which together as a team, enable then to execute exceptionally well as an organisation. I have found their expert knowledge and experience of the TGA and FDA regulations and environments, as well as Good Clinical Practice requirements to be invaluable. In particular, their real-world knowledge of these issues has been particularly important with several projects.
Additionally, I have also found the small, streamlined aspect of their organisation to be a benefit, as it enables them to navigate quickly to address client business needs more efficiently in terms of time and cost compared to many larger CROs.
Simply stated they have the ability to understand the critical path to a successful project execution in a way that is known and understood by their entire team.
In closing, I have no reservations in recommending Mobius Medical for and CRO related activates you may be contemplating.
Mobius provided us with high quality professional CRO services to initiate, conduct, and close out our trial. Of critical importance to the success of the trial, they identified high quality clinical centres, completed the regulatory submissions to government agencies and ethics committees, developed and supported the clinical trial database and provided much needed expertise regarding local laws and regulations.
We would definitely use Mobius for any future clinical trial needs in Australia/New Zealand.
The Mobius Team has allowed us to achieve our study enrollment and data collection milestones on time, in a high quality manner, and within budget. I have recommended Mobius to my CEO colleagues and would work with the Mobius Team again on future clinical trials in Australia and New Zealand.